Nabriva Therapeutics plc Annual Earnings Per Share, Basic in USD/shares from 2014 to 2022

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Nabriva Therapeutics plc quarterly/annual Earnings Per Share, Basic history and growth rate from 2014 to 2022.
  • Nabriva Therapeutics plc Earnings Per Share, Basic for the quarter ending June 30, 2023 was -3.73 USD/shares, a 14.8% increase year-over-year.
  • Nabriva Therapeutics plc Earnings Per Share, Basic for the twelve months ending June 30, 2023 was -18.4 USD/shares, a 50.5% increase year-over-year.
  • Nabriva Therapeutics plc annual Earnings Per Share, Basic for 2022 was -21.3 USD/shares, a 25.2% increase from 2021.
  • Nabriva Therapeutics plc annual Earnings Per Share, Basic for 2021 was -28.5 USD/shares, a 78.9% increase from 2020.
  • Nabriva Therapeutics plc annual Earnings Per Share, Basic for 2020 was -135 USD/shares, a 1113% decline from 2019.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$21 +$7.20 +25.2% Jan 1, 2022 Dec 31, 2022 10-K 2023-04-17
2021 -$29 +$107 +78.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-17
2020 -$135 -$124 -1113% Jan 1, 2020 Dec 31, 2020 10-K 2023-04-17
2019 -$11 Jan 1, 2019 Dec 31, 2019 10-K 2022-03-29
2016 -$26 +$22.50 +46.8% Jan 1, 2016 Dec 31, 2016 10-K 2017-03-24
2015 -$48 -$4 -8.2% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-24
2014 -$44 Jan 1, 2014 Dec 31, 2014 10-K 2017-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.